Evidence map›Paper›PMID 40050642›Full record

SynthesisScientific reports2025

Seroprevalence of SARS-CoV-2 antibodies among oral health care workers with natural seroconversion: a systematic review and meta-analysis.

Elisabeth Santigli, Marlene Lindner, Harald H Kessler, Norbert Jakse, Omid Fakheran

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elisabeth SantigliDivision of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health, Medical University of Graz, Billrothgasse 4, Graz, A- 8010, Austria. elisabeth.santigli@medunigraz.at.
Marlene LindnerDivision of Restorative Dentistry, Periodontology and Prosthodontics, Department of Dental Medicine and Oral Health, Medical University of Graz, Graz, Austria.
Harald H KesslerDiagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.
Norbert JakseDivision of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health, Medical University of Graz, Billrothgasse 4, Graz, A- 8010, Austria.
Omid FakheranDivision of Oral Surgery and Orthodontics, Department of Dental Medicine and Oral Health, Medical University of Graz, Billrothgasse 4, Graz, A- 8010, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aerosol and droplet exposure makes oral health care workers (OHCWs) highly susceptible to transmissible infections, for example with SARS-CoV-2. Population-based screening is useful in understanding public health interventions in COVID-19. This systematic review with meta-analysis presents the prevalence of SARS-CoV-2 antibodies among OHCWs. An electronic search has been performed to identify records indexed in Medline, Web of Science, Scopus, and the Cochrane Library until December 2023. All observational studies providing data on SARS-CoV-2 antibodies in OHCWs with natural seroconversion were included. The quality of 722 records was evaluated using the Joana Brigg's Institute (JBI) critical appraisal tool. Finally, ten studies were considered as eligible encompassing point-seroprevalence data on 6,083 dental professionals (dentists, assistants, and administrative staff) from seven European countries and Brazil. The antibody seroprevalence was pooled by a meta-analysis performed with MedCalc® statistical software. Applying random effects model, the overall seroprevalence of immunoglobulin G antibodies among OHCWs was estimated at 13.49% (95% CI 9.15-18.52%). The data indicate a somewhat increased occupation-specific risk for COVID-19 but more studies are required, especially later in the pandemic and following vaccination.

Indexed as

Antibodies, ViralCOVID-19Health PersonnelSARS-CoV-2HumansImmunoglobulin GSeroconversionSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GAntibodyCOVID-19Health personnelSARS-CoV-2Seroprevalence

Identifiers

PMID40050642
PMCPMC11885579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.